These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6374679)

  • 1. Nabumetone: a double-blind study in osteoarthrosis.
    Gillgrass J; Grahame R
    Pharmatherapeutica; 1984; 3(9):592-4. PubMed ID: 6374679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis of the knee and hip.
    Ginsberg F; Famaey JP
    J Int Med Res; 1982; 10(4):209-13. PubMed ID: 7117677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.
    Pisko EJ; Strader K; Rice D; White R; Goodman LA
    Pharmatherapeutica; 1987; 5(2):90-8. PubMed ID: 3310020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis.
    Verbruggen LA; Cytryn E; Pintens H
    J Int Med Res; 1982; 10(4):214-8. PubMed ID: 7117678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
    Blechman WJ
    Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients.
    Kim J; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Lee YJ; Ryu H; Lee KH; Song YW
    Clin Ther; 2009 Dec; 31(12):2860-72. PubMed ID: 20110025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.
    Weaver A; Rubin B; Caldwell J; McMahon FG; Lee D; Makarowski W; Offenberg H; Sack M; Sikes D; Trapp R
    Clin Ther; 1995; 17(4):735-45. PubMed ID: 8565037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.
    Makarowski W; Weaver A; Rubin B; Caldwell J; McMahon FG; Noveck RJ; Lee D; Offenberg H; Sack M; Sikes D; Trapp R; Rush S; Kuss M; Ganju J; Bocanegra TS; Ratliff JM
    Clin Ther; 1996; 18(1):114-24. PubMed ID: 8851458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nabumetone versus naproxen in the treatment of osteoarthritis. A six-month trial.
    Poiley JE
    Am J Med; 1987 Oct; 83(4B):82-5. PubMed ID: 3318435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
    Fleischmann RM; Flint K; Constantine G; Kolecki B
    Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis.
    Pisko EJ; Bockow BI; Box P; Brodsky AL; Burch FX; Collins RL; Fleischmann RM; Keller MI; Lipani JA; Poiley JE
    Am J Med; 1987 Oct; 83(4B):86-91. PubMed ID: 3318436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nabumetone, a new non-steroidal anti-inflammatory drug: a comparison with naproxen.
    Richards AM; Burry HC; Treadwell BL; Tweed JM; Mowles E
    N Z Med J; 1983 Dec; 96(745):1015-6. PubMed ID: 6361628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis.
    Mullen BJ
    Am J Med; 1987 Oct; 83(4B):74-7. PubMed ID: 3318433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effectiveness and safety of two non-steroidal anti-inflammatory agents, nabumetone and naproxen in rheumatoid arthritis.
    Fostiropoulos G; Croydon EA
    J Int Med Res; 1982; 10(4):204-8. PubMed ID: 6749576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind study of nabumetone and piroxicam in the treatment of osteoarthritis in Dutch general practice: efficacy and tolerability.
    De Bock GH; Hermans J; Mulder JD
    Pharm World Sci; 1993 Jun; 15(3):132-8. PubMed ID: 8348110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of nabumetone in the treatment of osteoarthritis of the knee joint: an open trial.
    Ben Dallah SK; Lenghi M
    J Int Med Res; 1994; 22(4):218-24. PubMed ID: 7958381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A non-steroidal antirheumatic agent (nabumetone): effectiveness and tolerance in short and long-term use].
    Singer F; Kolarz G; Scherak O
    Z Rheumatol; 1983; 42(2):82-5. PubMed ID: 6410605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice.
    Carle WK; Wade AG; Kill DC; Poland M
    J Rheumatol Suppl; 1992 Nov; 36():58-62. PubMed ID: 1474536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.